TAG
PRNewswire
Chenghe Acquisition II Co. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on July 29, 2024
SINGAPORE, July 27, 2024 /PRNewswire/ -- Chenghe Acquisition II Co. (the "Company") today announced that, commencing on July 29, 2024, holders of the units...
vivo Unveils Future Imaging Trends and Announces Winners of VISION+ Mobile PhotoAwards 2024
XINING, China, July 27, 2024 /PRNewswire/ -- vivo today held the 2024 vivo Imaging Conference in Xining, China, where it showcased vivo's latest advancements in...
Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small...
The positive CHMP opinion is based on results from the Phase II PHAROS trial, which demonstrated an objective response rate (ORR) of 75%...
